Search
Close this search box.
    • Small Molecules
      • Discovery
    • Biologics
    • Other Drug Modalities
    • SynVent Integrated Drug Discovery
      • SynVent Integrated Drug Discovery

        SynVent is Syngene’s platform for fully integrated therapeutic discovery and development across large and small molecules. 

    • Industries
    • Emerging Biopharma
      • Emerging Biopharma

        Emerging biopharma work at the forefront of science, often venturing into disease areas where little or no real-world data exists to work with or regulatory frameworks to work within.

    • Dedicated Centers
      • Dedicated Centers

        Our Dedicated Centers offer dedicated multi-disciplinary scientific teams, support personnel, and a tailormade ring-fenced and fire-walled infrastructure as per client specifications to support their  R&D  goals

    • Center for Advanced Protein Studies (CAPS)
      • Center for Advanced Protein Studies (CAPS)

        Centre for Advanced Protein Studies [CAPS] is a state-of-the-art advanced national facility located in the Syngene campus, Bangalore.

  • Careers
Search
Close this search box.

Establish accurate safety profile - from screening to IND submission

Explore a wide array of in-vitro and geno tox studies tailored to your specific needs. Our comprehensive offerings cover various aspects of genetic toxicology, allowing you to make informed decisions.

Establish accurate safety profile - from screening to IND submission

Precision and reliability are highly important when it comes to toxicology analysis. Our team of experienced scientists and state-of-the-art facilities ensure that you receive reports you can trust.
Our studies strictly adhere to the guidelines established by the Organization for Economic Co-operation and Development (OECD), ensuring international acceptance and regulatory compliance.
At Syngene, we take pride in delivering cost-effective services that set the gold standard for industry timelines. We understand that in today’s fast-paced business world, both budget constraints and strict project deadlines are at the forefront of your concerns.
From initial screening to Investigational New Drug (IND) submission, we support you at every stage of drug development. Our services cater to both small and large molecules.

Our range of genetic toxicology studies include:

Why Choose us?

Accurate Toxicology Reports
Precision and reliability are highly important when it comes to toxicology analysis. Our team of experienced scientists and state-of-the-art facilities ensure that you receive reports you can trust.

Studies as per OECD Guidelines
Our studies strictly adhere to the guidelines established by the Organization for Economic Co-operation and Development (OECD), ensuring international acceptance and regulatory compliance.

Cost effective services with best in the industry timelines
At Syngene, we take pride in delivering cost-effective services that set the gold standard for industry timelines. We understand that in today’s fast-paced business world, both budget constraints and strict project deadlines are at the forefront of your concerns.
End to end services
From initial screening to Investigational New Drug (IND) submission, we support you at every stage of drug development. Our services cater to both small and large molecules.

Customer Speak

As a pioneer in stem cell research and treatment in Malaysia, Cytopeutics Sdn. Bhd. has worked extensively with Syngene on multiple preclinical projects such as safety (toxicity and tumorigenicity) and proof-of-concept studies for our new investigational product. We were consistently impressed with how efficiently the studies were initiated and progressed, within the stipulated timeline, despite the incredibly tight schedule and budget. We are extremely pleased with Syngene’s outstanding quality of work, excellent professionalism, and the high level of dedication of each team member to our studies. With Syngene’s help, we could complete our preclinical studies in time to support our clinical trials and product registration requirements. We look forward to working together again.
Dr. Chin Sze Piaw
Clinical and Research Advisor, Cytopeutics Sdn. Bhd., Malaysia

Resources

Catalogue of Regulatory In Vitro and Genetic Toxicology Screening Assays
syngene-delivered
How Syngene delivered pre-IND to IND Safety studies for a leading biotech company in just three months
How Syngene's safety tox package helped Cytopeutics to advance its cell therapy drug to the Clinic
Safety Assessment services
Your pre-clinical toxicology program needs a strategy

Your browser does not support this function.

To download, Please share your details

This Website uses Cookies

We use cookies to improve your experience on our site and show you information relevant to your requirements.

To find out more, read our Privacy Policy, Cookies Policy and .

To view or email, Please share your details view

To download, Please share your details